LAB
LAB
NASDAQ · Life Sciences Tools & Services

Standard Biotools Inc

$0.62
+0.01 (+1.04%)
As of Nov 7, 2:03 AM ET ·
Analyst Consensus
Buy
6
Analysts
Moderate
Coverage
Buy 4 67%
Hold 2 33%
Sell 0 0%
Price Target
Analyst Price Target +4,856.6% upside
Low Target $24.11
Average Target $30.85
High Target $37.88
Current Price $0.62
Current
$0.62
Target
$30.85
$24.11 $30.85 avg $37.88
Scenario Analysis
Bear Case
$24.11
3,773.7%
Low target
Base Case
$30.85
+4,856.6%
Avg target
Bull Case
$37.88
+5,986.1%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$1.72
-63.8% from high
52-Week Low
$0.59
+5.8% from low
Target vs 52W High
$30.85
+1,693.6% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.02
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 35 86% $369.21 -46.9%
DHR
Danaher Corp
Strong Buy 31 87% $158.11 -31.3%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -63.0%
IQV
Iqvia Holdings Inc
Strong Buy 27 85% $82.96 -69.5%
WAT
Waters Corp
Buy 30 70% $189.60 -58.6%
MTD
Mettler-Toledo International
Hold 19 47% $170.43 -90.1%
ILMN
Illumina Inc
Buy 28 57% $169.36 -20.5%
WST
West Pharmaceutical Services
Strong Buy 22 95% $136.24 -65.9%